Juraj Konc is a postdoctoral researcher at St. Anna Children's Cancer Research Institute (CCRI) and CeMM, focusing on immune deficiency, cancer predisposition, and precision oncology under the guidance of Prof. Kaan Boztug. Juraj Konc has developed novel immunotherapeutic strategies for high-risk neuroblastoma. Prior to this, Juraj Konc completed a PhD in Chemistry at the University of Cambridge, working in the biological chemistry research group of Prof. Gonçalo Bernardes, where protocols for chemical modification of antibodies and DNA were developed, alongside bioorthogonal chemistry approaches for prodrug activation therapy. Educational background includes a Master's degree in Organic Chemistry and a Bachelor's degree in Clinical and Toxicological Analysis from Charles University. Juraj Konc has also held a laboratory technician position at IOCB Prague, where the synthesis of sugar-modified ribonucleoside derivatives for biological activity screening was conducted.
This person is not in any offices